Log In
Print
BCIQ
Print
Print this Print this
 

Invega Sustenna, Xeplion (paliperidone palmitate)

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionOnce-monthly intramuscular injection of paliperidone, a metabolite of risperidone
Molecular Target Monoamine receptors
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSchizophrenia
Indication DetailsTreat schizoaffective disorder; Treat schizophrenia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today